findmyKOL

Viresh Mohanlal, MD

Basic profile

Orlando Health

ORCIDNone on fileNPI
RegionOrlando, FL · SoutheastSpecialtyNephrologyFocusNephrology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Viresh Mohanlal is a Nephrology physician affiliated with Orlando Health. OpenAlex indexes 9 publications with 203 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
9publications

Distinct works indexed by OpenAlex.

203citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    59.7%
    Angiotensin receptor blocker (ARB)14.8%
    Losartan Potassium92%Telmisartan8%
    Part D<11 patients
    Calcium channel blocker14.1%
    Amlodipine Besylate78%Nifedipine Er22%
    Part D41 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    24.6%
    SGLT2 inhibitor12.2%
    Farxiga89%Jardiance11%
    Part D<11 patients
    Potassium supplement3.1%
    Potassium Chloride100%
    Part D11 patients

    + 5 more classes in this area

  • Other

    4.7%
    Phosphate Binder3.3%
    Sevelamer Carbonate100%
    Part D12 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia1.4%
    Lokelma100%
    Part D<11 patients
Where care is delivered (Part B)78.6% facility · 21.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”